NIDEK Receives FDA clearance for Excimer Laser System Model CXIII

Fremont, California. November 22, 2006

NIDEK Inc. a global leader in laser and diagnostic instrumentation for the optical and eye care industry, announced that it has received marketing clearance from the Food and Drug Administration (FDA), for its advanced refractive laser surgery system the CXIII EC-5000 Excimer Laser System. With this clearance, NIDEK continues to deliver the latest vision correction solutions to ophthalmologists around the world.

“This clearance is a great step forward and NIDEK is excited to be in a position to help doctors ensure good quality of life for their patients.” said Motoki Ozawa, CEO and President of NIDEK Incorporated.

CXIII, which is already CE-marked approved, offers the latest, innovative solutions for Myopia, Myopic Astigmatism, Hyperopia and Hyperopic Astigmatism in the US. CXIII includes a built-in 200 Hz eye tracker and also available is a built-in LCD “heads-up” monitor that displays operation mode, parameter settings, microns of ablation and image of the patient’s eye for tracking as optional.